قراءة
عرض

Microbiology

Medical bacteriology
Dr. Zainab D. Degaim
Microbiology
Medical bacteriology
Dr. Zainab D. Degaim

The Vibrios

Vibrios are among the most common bacteria in surface waters worldwide. They are curved aerobic rods and are motile, possessing a polar flagellum.
V cholerae serogroups O1 and O139 cause cholera in humans, and other vibrios may cause skin and soft tissue infections, sepsis, or enteritis.
Vibrio cholerae
Morphology and Identification
A. Typical Organisms
Upon first isolation, V cholerae is a comma-shaped, curved rod 2–4 μm long.
It is actively motile by means of a polar flagellum.
On prolonged cultivation, vibrios may become straight rods that resemble the Gram-negative enteric bacteria.
B. Culture
V cholerae produces convex, smooth, round colonies that are opaque and granular in transmitted light. V cholera and most other vibrios grow well at 37°C on many kinds of media, including defined media containing mineral salts and asparagine as sources of carbon and nitrogen.
V cholera grows well on thiosulfate-citrate-bile-sucrose (TCBS) agar, a media selective for vibrios, on which it produces yellow colonies (sucrose fermented) that are readily visible against the dark-green background of the agar.
Vibrios are oxidase positive, which differentiates them from enteric Gram-negative bacteria.
Characteristically, vibrios grow at a very high pH (8.5–9.5) and are rapidly killed by acid.
Cultures containing fermentable carbohydrates therefore quickly become sterile.
C. Growth Characteristics
V cholerae regularly ferments sucrose and mannose but not arabinose.
A positive oxidase test result is a key step in the preliminary identification of V cholerae and other vibrios.
Most Vibrio species are halotolerant, and NaCl often stimulates their growth.
Some vibrios are halophilic, requiring the presence of NaCl to grow.
Antigenic Structure and Biologic Classification
Many vibrios share a single heat-labile flagellar H antigen. Antibodies to the H antigen are probably not involved in the protection of susceptible hosts.
V cholerae has O lipopolysaccharides that confer serologic specificity.
There are at least 206 O antigen groups.
V cholerae strains of O group 1 and O group 139 cause classic cholera; occasionally, non-O1/non-O139 V cholerae causes cholera-like disease. Antibodies to the O antigens tend to protect laboratory animals against infections with V cholerae.
The V cholerae serogroup O1 antigen has determinants that make possible further typing; the serotypes are Ogawa, Inaba, and Hikojima.
Two biotypes of epidemic V cholera have been defined, classic and El Tor. The El Tor biotype produces a hemolysin, gives positive results on the Voges-Proskauer test, and is resistant to polymyxin B.
Molecular techniques can also be used to type V cholerae. Typing is used for epidemiologic studies, and tests generally are done only in reference laboratories.
V cholerae O139 is very similar to V cholerae O1 El Tor biotype. V cholerae O139 does not produce the O1 lipopolysaccharide and does not have all the genes necessary to make this antigen. V cholerae O139 makes a polysaccharide capsule like other non-O1 V cholerae strains, but V cholerae O1 does not make a capsule.


Vibrio cholerae Enterotoxin
V. cholerae produce a heat-labile enterotoxin with a molecular weight (MW) of about 84,000, consisting of subunits A (MW, 28,000) and B. Ganglioside GM1 serves as the mucosal receptor for subunit B, which promotes entry of subunit A into the cell. Activation of subunit A1 yields increased levels of intracellular cyclic adenosine monophosphate (cAMP) and results in prolonged hypersecretion of water and electrolytes. There is increased sodium-dependent chloride secretion, and absorption of sodium and chloride by the microvilli is inhibited. Electrolyte-rich diarrhea occurs— as much as 20–30 L/day—with resulting dehydration, shock, acidosis, and death. The genes for V cholerae enterotoxin are on the bacterial chromosome. Cholera enterotoxin is antigenically related to LT of Escherichia coli and can stimulate the production of neutralizing antibodies. However, the precise role of antitoxic and antibacterial antibodies in protection against cholera is not clear.
Pathogenesis and Pathology
Under natural conditions, V cholerae is pathogenic only for humans. A person with normal gastric acidity may have to ingest as many as 1010 or more V cholerae to become infected when the vehicle is water because the organisms are susceptible to acid. When the vehicle is food, as few as 102–104 organisms are necessary because of the buffering capacity of food. Any medication or condition that decreases stomach acidity makes a person more susceptible to infection with V cholerae.
Cholera is not an invasive infection. The organisms do not reach the bloodstream but remain within the intestinal tract. Virulent V cholerae organisms attach to the microvilli of the brush border of epithelial cells. There they multiply and liberate cholera toxin and perhaps mucinases and endotoxin.

Clinical Findings

About 50% of infections with classic V cholerae are asymptomatic, as are about 75% of infections with the El Tor biotype. The incubation period is 12 hours–3 days for persons who develop symptoms, depending largely on the size of the inoculum ingested.
There is a sudden onset of nausea and vomiting and profuse diarrhea with abdominal cramps.
Stools, which resemble “rice water,” contain mucus, epithelial cells, and large numbers of vibrios.
There is rapid loss of fluid and electrolytes, which leads to profound dehydration, circulatory collapse, and anuria.
The mortality rate without treatment is between 25% and 50%. The diagnosis of a full-blown case of cholera presents no problem in the presence of an epidemic.
However, sporadic or mild cases are not readily differentiated from other diarrheal diseases. The El Tor biotype tends to cause milder disease than the classic biotype.
Diagnostic Laboratory Tests
A. Specimens
Specimens for culture consist of mucus flecks from stools.
B. Smears
The microscopic appearance of smears made from stool samples is not distinctive. Dark-field or phase contrast microscopy may show the rapidly motile vibrios.
C. Culture
Growth is rapid in peptone agar, on blood agar with a pH near 9.0, or on TCBS agar, and typical colonies can be picked in 18 hours. For enrichment, a few drops of stool can be incubated for 6–8 hours in taurocholate peptone broth (pH, 8.0–9.0); organisms from this culture can be stained or subcultured. Accurate identification of vibrios, including V cholerae, using commercial systems and kit assays is quite variable.
D. Specific Tests
V cholerae organisms are further identified by slide agglutination tests using anti-O group 1 or group 139 antisera and by biochemical reaction patterns. The diagnosis of cholera under field conditions has been reported to be facilitated by a
sensitive and specific immunochromatographic dipstick test.
Immunity
Gastric acid provides some protection against cholera vibrios.
An attack of cholera is followed by immunity to reinfection, but the duration and degree of immunity are not known.
In experimental animals, specific IgA antibodies occur in the lumen of the intestine.
Similar antibodies in serum develop after infection but last only a few months. Vibriocidal antibodies in serum (titer ≥1:20) have been associated with protection against colonization and disease.
The presence of antitoxin antibodies has not been associated with protection.
Treatment
The most important part of therapy consists of water and electrolyte replacement to correct the severe dehydration and salt depletion.
Many antimicrobial agents are effective against V cholerae, but these play a secondary role in patient management. Oral tetracycline and doxycycline tend to reduce stool output in cholera and shorten the period of excretion of vibrios.
In some endemic areas, tetracycline resistance of V cholerae has emerged; the genes are carried by transmissible plasmids.
In children and pregnant women, alternatives to the tetracyclines include erythromycin and furazolidine.


Epidemiology, Prevention, and Control
Six pandemics (worldwide epidemics) of cholera occurred between 1817 and 1923 caused most likely by V cholerae O1 of the classic biotype and largely originating in Asia, usually the Indian subcontinent.
The seventh pandemic began in 1961 in the Celebes Islands, Indonesia, with spread to Asia, the Middle East, and Africa. This pandemic was caused by V cholerae biotype El Tor. Starting in 1991, the seventh pandemic spread to Peru and then to other countries of South America and Central America. Cases also occurred in Africa Millions of people have had cholera in this pandemic.
Some consider the cholera caused by the serotype O139 strain to be the eighth pandemic that began in the Indian subcontinent in 1992–1993, with spread to Asia. The disease has been rare in North America since the mid-1800s, but an endemic focus exists on the Gulf Coast of Louisiana and Texas. Cholera is endemic in India and Southeast Asia.




رفعت المحاضرة من قبل: Mubark Wilkins
المشاهدات: لقد قام 5 أعضاء و 72 زائراً بقراءة هذه المحاضرة








تسجيل دخول

أو
عبر الحساب الاعتيادي
الرجاء كتابة البريد الالكتروني بشكل صحيح
الرجاء كتابة كلمة المرور
لست عضواً في موقع محاضراتي؟
اضغط هنا للتسجيل